Meet John Park, MD

John Park, MD

Dr. John Park received a Bachelor of Science degree from Brown University. He completed medical and graduate school at Harvard University, and a residency in neurosurgery at Harvard Medical School, Brigham and Women’s Hospital and Boston Children’s Hospital. Following residency, he joined the Harvard faculty and the medical staffs of Boston Children’s Hospital, Brigham and Women’s Hospital and Dana-Farber Cancer Institute. Dr. Park subspecialized in brain and spinal tumors and also practiced general neurosurgery.

In 2002, he was recruited to the National Institutes of Health to become chief of Surgical and Molecular Neuro-oncology. He was the principal investigator of a basic and translational science laboratory within the National Institute of Neurological Disorders and Stroke and served as the primary brain tumor surgeon for the National Cancer Institute.

He has authored numerous clinical, translational and basic science publications and has received awards from the National Institutes of Health, the American Brain Tumor Association, the Joint Pediatric Section of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons (AANS/CNS), the Joint Tumor Section of the AANS/CNS, the New England Cancer Society, and the Neurosurgery Research and Education Foundation.

A board certified neurosurgeon, Dr. Park specializes in the surgical treatment of patients with primary and metastatic brain tumors, pituitary tumors and spine tumors and also treats patients with neck and back pain due to degenerative spinal disorders.

He joined Cottage Health in 2013 after a two-year search for a top-tier, nationally renowned brain tumor surgeon by the Santa Barbara Neuroscience Institute. Dr. Park helped guide the addition of the institute’s intraoperative magnetic resonance imaging (iMRI) suite, which allows neurosurgeons to better distinguish between normal and diseased tissues when removing tumors. “The iMRI will add to the already extensive armamentarium of cutting edge technologies that we offer at Cottage Health,” says Dr. Park, who worked with the world’s first iMRI when it was introduced at Brigham and Women’s Hospital.

Videos Featuring John Park, MD

John Park, MDDr. Park Helps Joe Huerta Beat Brain Cancer

Joe Huerta and Cottage Santa Barbara Neuroscience Institute's John Park, MD, developed a successful surgical plan that let Joe get back to the life he loved before the brain cancer diagnosis.

Watch Video

John Park, MD

Brain and Spinal Tumors

John Park, MD speaks about brain and spinal tumors. What to know when speaking to a specialist, staff and understanding the treatments available.

Watch Video

Articles and Case Studies by John Park, MD

Neurotransmitter Magazine Spring 2015

"Advanced Imaging and Surgical Technologies in Santa Barbara"

NEUROtransmitter Magazine, Spring 2015

At SBNI, we employ some of the most ad- vanced imaging and surgical technologies available to treat brain and spinal tumors. Typically, these technologies and treatments are found only in major academic medical centers and rarely in a community the size of Santa Barbara.

Read the full article

Neurotransmitter Magazine Spring 2015"Tumor Resection from Eloquent Brain Areas"

NEUROtransmitter Magazine, Spring 2015

Combined use of intraoperative MRI and intraoperative electrical brain stimulation may allow for resection of tumors previously considered unresectable, with a significantly decreased risk of new neurologic deficit, potentially prolonging survival and increasing quality of life.

Read the full article

Neurotransmitter Magazine Summer 2014"Surgical Management of Glioblastoma"

NEUROtransmitter Magazine, Summer 2014

While surgical removal is the generally accepted treatment for initially diagnosed glioblastoma, there is no such agreement on the treatment of recurrent GBM tumors.

Read the full article

Neurotransmitter Magazine Spring 2014

"An Overview of Meningiomas: Presentation, Diagnosis and Treatment"

NEUROtransmitter Magazine, Spring 2014

Meningiomas are the most common tumors of the central nervous system (CNS) and account for more than one third of all CNS tumors. They occur at an average annual age-adjusted incidence rate of 7.44 per 100,000 and from 2006–2010, 116,986 cases were diagnosed in the United States.

Read the full article

Neurotransmitter Magazine Fall 2013

"Maximizing Surgical Resection of Glioblastomas—Using Intraoperative MRI"

NEUROtransmitter Magazine, Fall 2013

Gliomas are the most common primary tumors of the brain. they arise from the neoplastic transformation of neural stem cells or of glial cells such as astrocytes or oligodendrocytes.

Read the full article